#clgn

StockTitan

@stocktitan.net

4 days ago

Biotech CollPlant to unveil 2025 results before U.S. market open Full-year 2025 report lands March 26, 2026 before U.S. markets open, as CollPlant Biotechnologies prepares to release its annual financial results.

#CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

2 weeks ago

Korean patent positions CollPlant in $6B injectable facial filler market Patent protection through 2039 in South Korea strengthens CollPlant’s photocurable dermal filler platform for a global soft-tissue market above $6B.

#CLGN CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler

www.stocktitan.net/news/CLGN/coll-plant-bio...

@prinzalbertmen68.bsky.social

2 weeks ago

#clgn #hotel #pissplay #goodmen #fullbush #tattoos #cockrinf #PAmen

StockTitan

@stocktitan.net

3 months ago

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE CollPlant Biotechnologies (Nasdaq: CLGN) reported third-quarter 2025 results and a corporate update on Nov 26, 2025. Key commercial moves include a new U.S. logistics center becoming operational this quarter and appointment of a North America commercial head to expand rhCollagen and BioInk distribution.Financial highlights: Q3 GAAP revenue $77k (vs $4k year-ago); 9M revenue $2.3M driven by a $2.0M AbbVie milestone; cash $8.5M as of Sept 30, 2025; GAAP 9M net loss narrowed to $8.3M from $12.7M. Company initiated a ~25% workforce reduction and cost-prioritization to extend runway.

#CLGN COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

3 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS CollPlant Biotechnologies (Nasdaq: CLGN) announced it will report third quarter 2025 financial results on Wednesday, November 26, 2025, before the U.S. market open. The company develops non-animal-derived rhCollagen products for tissue regeneration and medical aesthetics. Investors can expect the company to release results and any accompanying commentary or materials on that date.

#CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

4 months ago

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk The bioprinted skin model is designed to serve as an alternative to animal testing for preclinical research. According to a scientific article published in the Archives of Dermatological Research, the model developed by Mayo Clinic researchers combines CollPlant's plant-derived recombinant human collagen with distinct and essential human skin cell...

#CLGN First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

www.stocktitan.net/news/CLGN/first-in-kind-...

Small Cap Strategist

@smcapstrategist.bsky.social

5 months ago

Small-cap stocks gapping down in trading, Tue Sept 30th - #ATCH #NBY #YAAS #RAYA #GOVX #FLY #BIAF #ABEB #SCYX #CREG #CLGN #BNRG - More: crystalequityresearch.com/trade-alerts... - #smallcap

StockTitan

@stocktitan.net

5 months ago

Light-Activated Dermal Filler Breakthrough: CollPlant's rhCollagen Tech Shows 1-Year Durability in Studies CollPlant's innovative dermal filler combines hyaluronic acid with rhCollagen, demonstrating long-term durability in 1-year study. Product advances to clinical trials with unique light-activation mechanism.

#CLGN CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

www.stocktitan.net/news/CLGN/coll-plant-bio...

StockTitan

@stocktitan.net

6 months ago

Revolutionary Tendon Healing Matrix: CollPlant Expands VergenixSTR Distribution Across Europe with Polish Deal CollPlant's rhCollagen-based VergenixSTR for tendon injury treatment expands to Poland. Product combines with PRP for sustained healing in tennis elbow, rotator cuff, and Achilles injuries.

#CLGN CollPlant Expands the Distribution of its VergenixSTR Product in Europe

www.stocktitan.net/news/CLGN/coll-plant-exp...

StockTitan

@stocktitan.net

6 months ago

$2M AbbVie Milestone: CollPlant Advances Revolutionary Regenerative Breast Implants and Dermal Fillers CollPlant reports Q2 revenue of $179K, H1 revenue of $2.2M including AbbVie milestone. Advances regenerative breast implants and dermal fillers. Raises $3.6M in direct offering with $11.4M cash position.

#CLGN COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

7 months ago

CollPlant Earnings: Leading Regenerative Medicine Biotech Sets Q2 Results Date Regenerative medicine leader CollPlant to reveal Q2 performance on August 20. Get insights on rhCollagen technology progress and financial metrics. See details.

#CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

9 months ago

CollPlant's Plant-Based Collagen Advances to Clinical Applications in Major STEMCELL Technologies Deal CollPlant's rhCollagen technology moves beyond research into clinical and commercial applications. Partnership expansion signals major advancement in sustainable biotech. Learn more.

#CLGN COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

www.stocktitan.net/news/CLGN/collplant-broa...

StockTitan

@stocktitan.net

9 months ago

CollPlant Secures Game-Changing Patent Win: Targets $9B Beauty Market with Revolutionary Collagen Technology European patent strengthens CollPlant's position in $6B fillers and $3B implants markets with innovative rhCollagen technology. See growth strategy.

#CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

www.stocktitan.net/news/CLGN/collplant-biot...

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

9 months ago

Nasdaq Down 100 Points; Chicago PMI Dips In May - Nuburu (AMEX:BURU), BioLine Rx (NASDAQ:BLRX)

Nasdaq Down 100 Points; Chicago PMI Dips In May read more

www.benzinga.com/cannabis/25/05/45698911/...

#BLRX #BURU #BWNB #CLGN #Earnings #Equities #GITS #MDCX #Mid #Morning #Market

Result Details

StockTitan

@stocktitan.net

9 months ago

CollPlant Raises $3.6M to Advance AbbVie Partnership and Breakthrough Regenerative Medicine Programs Fresh capital to accelerate CollPlant's dermal filler development with AbbVie and expand regenerative medicine pipeline. See strategic allocation details.

#CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

www.stocktitan.net/news/CLGN/collplant-biot...

Market Wire News

@marketwirenews.com

9 months ago

JUST IN: ( NASDAQ: #CLGN ) Expected US Company Earnings on Wednesday, May 28th, 2025

StockTitan

@stocktitan.net

9 months ago

CollPlant Earnings: $2M Milestone Payment Fuels Breakthrough in Regenerative Breast Implant Technology CollPlant receives $2M from AbbVie partnership, advances revolutionary regenerative breast implants. See latest clinical progress and financial metrics. Get insights.

#CLGN COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

10 months ago

CollPlant to Reveal Q1 2025 Performance: Regenerative Medicine Pioneer Reports Pre-Market May 28 Get key insights into CollPlant's Q1 2025 financial performance and regenerative medicine advances. Pre-market earnings call details now available. See full schedule.

#CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

11 months ago

CollPlant's $3B Breast Implant Breakthrough: Key Milestones Hit Despite Revenue Drop Latest data reveals successful 200cc breast implant printing and positive 6-month study results. AbbVie partnership yields $2M payment. Full financial analysis inside.

#CLGN #SSYS COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

11 months ago

CollPlant to Reveal Full Year 2024 Performance: Key Earnings Call Details Inside Join CollPlant's Q4 earnings call on March 26 at 10AM EST. Live webcast and dial-in available for US and international investors. Submit questions in advance for management Q&A.

#CLGN COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

www.stocktitan.net/news/CLGN/collplant-biot...

StockTitan

@stocktitan.net

1 year ago

Medical Breakthrough: CollPlant's Tendon Treatment Enters 4 New Markets - Why It Matters Strategic expansion brings innovative tendinopathy treatment to Benelux, Spain, Turkey, and India. First shipments completed with more markets pending approval.

#CLGN CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

www.stocktitan.net/news/CLGN/coll-plant-exp...

StockTitan

@stocktitan.net

1 year ago

Major Patent Win: CollPlant's Revolutionary Dermal Filler Technology Secures Protection Until 2039 CollPlant strengthens IP portfolio with new dermal filler patent, receives milestone payment from AbbVie, and implements strategic cost reductions to extend runway

#CLGN CollPlant Biotechnologies Provides a Corporate Update

www.stocktitan.net/news/CLGN/coll-plant-bio...

StockTitan

@stocktitan.net

1 year ago

#CLGN #SSYS COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

www.stocktitan.net/news/CLGN/collplant-biot...